- Home
- GNLX vs RFM Comparison
GNLX vs RFM Comparison
Compare GNLX & RFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$4.32
Company Overview
Basic Information| Metric | GNLX | RFM |
|---|---|---|
| Founded | 2001 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 202.4M | 86.2M |
| IPO Year | 2023 | N/A |
Fundamental Metrics
Financial Performance| Metric | GNLX | RFM |
|---|---|---|
| Price | $4.32 | $14.21 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $19.75 | N/A |
| AVG Volume (30 Days) | ★ 195.5K | 20.7K |
| Earning Date | 11-05-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 9.74% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.99 | $12.89 |
| 52 Week High | $8.54 | $16.41 |
Technical Indicators
Market Signals| Indicator | GNLX | RFM |
|---|---|---|
| Relative Strength Index (RSI) | 35.71 | 50.65 |
| Support Level | $4.37 | $14.01 |
| Resistance Level | $4.75 | $14.35 |
| Average True Range (ATR) | 0.42 | 0.11 |
| MACD | -0.04 | 0.02 |
| Stochastic Oscillator | 8.99 | 71.24 |
Price Performance
Historical Comparison GNLX
RFM
About GNLX Genelux Corporation
Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec), Lung, and Pancreatic Cancer.
About RFM RiverNorth Flexible Municipal Income Fund Inc.
RiverNorth Flexible Municipal Income Fund Inc is a diversified, closed-end management investment company. Its primary investment objective is to seek current income exempt from regular U.S. federal income taxes. The fund's secondary investment objective is total return.